The 4-day 2025 "InnoZone Innovative Technology Special Exhibit" concluded successfully on December 7 within the Taiwan Healthcare+ Expo. As the official pavilion for forward-looking technologies, InnoZone featured 130 technical achievements from "National Innovation Award" winning teams, serving as a critical barometer for Taiwan’s biomedical R&D and commercialization progress.

Six Emerging Technical Trends Locked on Clinical Needs

1. Medical Digital Transformation: To combat global healthcare labor shortages, teams presented solutions including GenAI medical assistants, automated nursing summaries/EMR generation, and smart pharmacy/ward management systems to liberate medical personnel from administrative burdens.
2. Risk Prediction & Early Screening: The focus shifted from "treatment" to "prediction." AI models were showcased for early detection of Dementia, Diabetes, Colonic Polyps, Osteoporosis, and Osteoarthritis. Notably, advances in Minimal Residual Disease (MRD) tracking allow oncologists to intervene before cancer recurrence.
3. Quantification of Treatment Outcomes: Moving from subjective experience to objective data, sensor technologies are now used to analyze previously "unquantifiable" data, such as masticatory/swallowing rehabilitation and cognitive function training, ensuring evidence-based efficacy.
4. Digitalization of Clinical Training: To reduce trial-and-error costs, teams utilized VR/AR, 3D modeling, and 3D printing combined with high-fidelity haptic feedback. This allows medical students to perform high-intensity drills in a zero-risk environment before treating actual patients.
5. Breakthrough Drug Development: New therapies target existing bottlenecks, including long-acting radiopharmaceuticals for prostate cancer, innovative treatments for Alzheimer’s and Chronic Kidney Disease (CKD), and nanotechnological eye drops for diabetic cataracts.
6. Agri-Food & Green Chemistry (ESG): Extending biomedical tech to sustainability, the exhibit featured the world-first "Zero-Carbon Process Metal/Sulfur Energy Storage Material." This technology addresses density and lifespan bottlenecks in Lithium-Sulfur batteries, showcasing Taiwan's R&D strength (ranked 4th globally in this field).

Integration of Regulatory and Commercial Ecosystems

The InnoZone opening featured high-level cross-ministerial support from Wu Hsing-fei (NSTC) and Wu Ting-yao (TFDA). Key strategic partners—including PwC (COO Lin Yung-chih) and Formosan Brothers Law Firm (Senior Partner Huang Shuai-sheng)—provided over 100 professional consultations on financing, taxation, and regulatory registration (TFDA/FDA). Support from institutions like KPMG, Kaohsiung Medical University, and National Taiwan University Hospital Hsinchu Branch further demonstrated the tight link between academic R&D and industrial application.

Accelerating Technology Liquidity

To accelerate "technology-to-cash" conversion, InnoZone hosted three Innovation & Entrepreneurship forums and selected 24 elite teams for competitive Roadshow presentations. Through numerous 1-on-1 matchmaking sessions, the platform connected National Innovation Award teams with global investors and industry leaders to facilitate technology transfer and joint development.

Resource: 匯聚 130 項生醫科研成果 InnoZone 創新技術特展驅動產業鏈結與商化落地